Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1998-03-06
1999-05-18
Degen, Nancy
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 691, 4353201, 435363, 536 235, C07H21/04
Patent
active
059051450
ABSTRACT:
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as TAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as TAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.
REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
patent: 5571711 (1996-11-01), Van Der Bruggen et al.
patent: 5610013 (1997-03-01), Van Den Eynde et al.
Boon-Falleur Thierry
van der Bruggen Pierre
Degen Nancy
Ludwig Institute for Cancer Research
LandOfFree
Isolated nucleic acid molecules which encode TAGE molecules, and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acid molecules which encode TAGE molecules, and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecules which encode TAGE molecules, and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760149